Ultragenyx Pharmaceutical...

35.69
0.71 (2.03%)
At close: Apr 17, 2025, 3:59 PM
35.69
0.00%
After-hours: Apr 17, 2025, 04:31 PM EDT

Ultragenyx Pharmaceutical Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for RARE stock have an median target of 84.5, with a low estimate of 48 and a high estimate of 136. The median target predicts an increase of 136.76% from the current stock price of 35.69.

Target Low Average Median High
Price $48 $92.79 $84.5 $136
Change 34.49% 159.99% 136.76% 281.06%

Latest Analyst Insight Report

Piper Sandler maintains an Overweight rating on Ul... Unlock content with Pro Subscription

Updated Mar 17, 2025

Rating Oct 24Nov 24Dec 24Jan 25Feb 25Mar 25
Strong Buy 120010
Buy 242232
Hold 000100
Sell 000000
Strong Sell 000000
Total 3 6 2 3 4 2

Financial Forecast this Year

Revenue This Year
655.64M
from 560.23M
Increased by 17.0%
Revenue Next Year
847.72M
from 655.64M
Increased by 29.3%
EPS This Year
-5.14
from -6.29
Increased by 18.3%
EPS Next Year
-3.6
from -5.14
Increased by 30.0%